KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
3.320
-0.010 (-0.30%)
Aug 19, 2026, 4:00 PM EDT - Market closed
KORU Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45.11 | 41.13 | 33.65 | 28.52 | 27.9 | 23.49 | |
Revenue Growth | 22.41% | 22.23% | 17.98% | 2.23% | 18.76% | -2.84% |
Cost of Revenue | 16.95 | 15.52 | 12.31 | 11.81 | 12.53 | 9.72 |
Gross Profit | 28.16 | 25.6 | 21.33 | 16.71 | 15.37 | 13.77 |
Selling, General & Admin | 24.56 | 23.38 | 21.63 | 20.37 | 20.61 | 17.86 |
Research & Development | 4.46 | 4.39 | 5.26 | 5.74 | 4.96 | 2.47 |
Operating Expenses | 29.81 | 28.58 | 27.78 | 26.98 | 26.15 | 20.8 |
Operating Income | -1.65 | -2.97 | -6.45 | -10.27 | -10.78 | -7.03 |
Interest & Investment Income | 0.28 | 0.29 | 0.44 | 0.56 | 0.15 | 0.01 |
Currency Exchange Gain (Loss) | -0.04 | 0.05 | -0.05 | -0.01 | -0.04 | -0.03 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | -0.02 | - | - | 0.68 |
EBT Excluding Unusual Items | -1.4 | -2.62 | -6.06 | -9.71 | -10.68 | -6.37 |
Gain (Loss) on Sale of Assets | -0.41 | - | - | -0.06 | - | 0 |
Pretax Income | -1.81 | -2.62 | -6.06 | -9.77 | -10.68 | -6.36 |
Income Tax Expense | 0.01 | 0.02 | 0 | 3.97 | -2.01 | -1.8 |
Net Income | -1.82 | -2.64 | -6.07 | -13.74 | -8.66 | -4.56 |
Net Income to Common | -1.82 | -2.64 | -6.07 | -13.74 | -8.66 | -4.56 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 45 | 44 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 45 | 44 |
Shares Change | 0.63% | 0.84% | 0.44% | 1.33% | 1.39% | 5.86% |
EPS (Basic) | -0.04 | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 |
EPS (Diluted) | -0.04 | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.78 | -0.47 | -1.62 | -5.68 | -8.17 | -4.67 |
Free Cash Flow Per Share | 0.02 | -0.01 | -0.04 | -0.12 | -0.18 | -0.10 |
Gross Margin | 62.43% | 62.26% | 63.40% | 58.59% | 55.09% | 58.62% |
Operating Margin | -3.66% | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% |
Profit Margin | -4.03% | -6.41% | -18.03% | -48.18% | -31.05% | -19.42% |
Free Cash Flow Margin | 1.72% | -1.14% | -4.81% | -19.90% | -29.27% | -19.86% |
EBITDA | -0.98 | -2.28 | -5.67 | -9.4 | -10.19 | -6.57 |
EBITDA Margin | -2.17% | -5.54% | -16.86% | -32.96% | -36.54% | -27.95% |
D&A For EBITDA | 0.67 | 0.69 | 0.77 | 0.87 | 0.59 | 0.46 |
EBIT | -1.65 | -2.97 | -6.45 | -10.27 | -10.78 | -7.03 |
EBIT Margin | -3.66% | -7.23% | -19.16% | -36.01% | -38.65% | -29.93% |